Holen Sie sich die Stockscreener-App
35.62
0.72%
-0.26
Vorhandelsmarkt:
36.75
1.13
+3.17%
Schlusskurs vom Vortag:
$35.88
Offen:
$36.12
24-Stunden-Volumen:
617.40K
Relative Volume:
0.51
Marktkapitalisierung:
$3.12B
Einnahmen:
$23.38M
Nettoeinkommen (Verlust:
$-155.22M
KGV:
-16.26
EPS:
-2.19
Netto-Cashflow:
$-134.36M
1W Leistung:
+4.80%
1M Leistung:
+7.32%
6M Leistung:
+82.11%
1J Leistung:
+31.97%
1-Tages-Spanne:
$35.20
$36.18
1-Wochen-Bereich:
$34.31
$36.55
52-Wochen-Spanne:
$13.45
$36.55
Ideaya Biosciences Inc Stock (IDYA) Company Profile
Firmenname
Ideaya Biosciences Inc
Sektor
Branche
Telefon
650-443-6209
Adresse
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie IDYA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
35.62 | 3.15B | 23.38M | -155.22M | -134.36M | -2.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Eingeleitet | Truist | Buy |
| 2025-09-18 | Eingeleitet | Guggenheim | Buy |
| 2025-09-04 | Eingeleitet | Barclays | Overweight |
| 2025-09-04 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-07-22 | Eingeleitet | TD Cowen | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2025-06-26 | Eingeleitet | Wells Fargo | Overweight |
| 2024-11-18 | Eingeleitet | Stephens | Overweight |
| 2024-11-05 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-08 | Eingeleitet | Mizuho | Outperform |
| 2024-03-08 | Eingeleitet | BTIG Research | Buy |
| 2023-08-08 | Eingeleitet | SVB Securities | Outperform |
| 2023-05-24 | Eingeleitet | Goldman | Buy |
| 2023-04-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-23 | Eingeleitet | Berenberg | Buy |
| 2023-02-28 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-28 | Eingeleitet | CapitalOne | Overweight |
| 2022-10-27 | Eingeleitet | Citigroup | Buy |
| 2022-08-15 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2022-03-10 | Hochstufung | Stifel | Hold → Buy |
| 2021-09-23 | Eingeleitet | Stifel | Hold |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-11 | Eingeleitet | Guggenheim | Buy |
| 2020-10-07 | Eingeleitet | Wedbush | Outperform |
| 2020-09-01 | Eingeleitet | Northland Capital | Outperform |
| 2020-07-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-13 | Eingeleitet | ROTH Capital | Buy |
| 2019-10-17 | Eingeleitet | Oppenheimer | Outperform |
| 2019-09-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-17 | Eingeleitet | Citigroup | Buy |
| 2019-06-17 | Eingeleitet | JP Morgan | Neutral |
| 2019-06-17 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Ideaya Biosciences Inc Aktie (IDYA) Neueste Nachrichten
IDEAYA receives FDA clearance for bispecific cancer drug IDE034 By Investing.com - Investing.com Australia
IDEAYA Biosciences Gets FDA Clearance to Begin Phase 1 Trial of IDE034 in Early 2026 - MarketScreener
Ideaya Biosciences announces clearance for IDE034 - MarketScreener
IDEAYA Biosciences (NASDAQ: IDYA) to launch Phase 1 IDE034 ADC trial in solid tumors - Stock Titan
A Closer Look at IDEAYA Biosciences (IDYA) Valuation as Investor Optimism Builds - Yahoo Finance
(IDYA) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Ideaya Biosciences announces inducement grants under Nasdaq listing rule - TipRanks
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Santa Maria Times
IDEAYA Biosciences to Participate in Upcoming December 2025 Investor Relations Events - Sahm
How sustainable is IDEAYA Biosciences Inc. stock dividend payoutJuly 2025 Decliners & Real-Time Volume Analysis Alerts - BỘ NỘI VỤ
Ideaya Biosciences: Primed For SuccessMajor Eye Cancer Catalyst Weeks Away (IDYA) - Seeking Alpha
Ideaya Biosciences stock reaches 52-week high of 35.13 USD By Investing.com - Investing.com India
Ideaya Biosciences stock reaches 52-week high of 35.13 USD - Investing.com
Is IDEAYA Biosciences Inc 30J a good long term investmentDividend Aristocrats List & Build Balanced Portfolio - earlytimes.in
Truist Securities initiates coverage on Ideaya Biosciences stock with Buy rating By Investing.com - Investing.com South Africa
IDEAYA Biosciences Turns a Profit in Q3 on Servier Partnership Revenue - MSN
Ideaya Biosciences: A Promising Investment as Key Clinical Data Nears - Ad-hoc-news.de
Truist Securities initiates coverage on Ideaya Biosciences stock with Buy rating - Investing.com Canada
IDEAYA Biosciences (NASDAQ: IDYA) at 2025 Citi and Evercore investor events - Stock Titan
EBITDA per share of IDEAYA Biosciences, Inc. – DUS:30J - TradingView
What analysts say about IDEAYA Biosciences Inc stockEarnings Season Recap & Unlock Smart Investment Tactics That Work - earlytimes.in
How higher bond yields impact IDEAYA Biosciences Inc. (30J) stockWeekly Trade Recap & Daily Risk Controlled Trade Plans - newser.com
Published on: 2025-11-20 07:13:14 - newser.com
Why IDEAYA Biosciences Inc. (30J) stock appears on watchlists2025 Market Overview & Risk Managed Trade Strategies - newser.com
What valuation multiples suggest for IDEAYA Biosciences Inc. stockQuarterly Earnings Summary & Capital Efficient Trading Techniques - newser.com
Will IDEAYA Biosciences Inc. (30J) stock top growth indexesWeekly Gains Report & Detailed Earnings Play Strategies - newser.com
Using AI based signals to follow IDEAYA Biosciences Inc.Market Trend Report & Fast Momentum Stock Entry Tips - newser.com
Will IDEAYA Biosciences Inc. (30J) stock beat revenue estimates2025 Market Outlook & AI Forecast Swing Trade Picks - newser.com
How IDEAYA Biosciences Inc. stock reacts to Fed rate cutsEarnings Risk Summary & Real-Time Price Movement Reports - newser.com
Will IDEAYA Biosciences Inc. stock see PE expansionGap Up & Weekly Chart Analysis and Trade Guides - newser.com
Will IDEAYA Biosciences Inc. (30J) stock profit from automation waveMarket Trend Report & Reliable Intraday Trade Alerts - newser.com
Published on: 2025-11-19 05:21:38 - newser.com
Will IDEAYA Biosciences Inc. (30J) stock extend growth storyWeekly Profit Analysis & AI Powered Market Entry Strategies - newser.com
Published on: 2025-11-19 03:26:31 - newser.com
Why retail investors pile into IDEAYA Biosciences Inc. stockProfit Target & Daily Oversold Bounce Ideas - newser.com
Is IDEAYA Biosciences Inc. stock entering bullish territoryMarket Sentiment Report & AI Forecast for Swing Trade Picks - newser.com
Jefferies Global Healthcare Conference - MarketScreener
IDEAYA Biosciences, Inc. (IDYA) AI-Powered Stock Analysis - Meyka
Price-Driven Insight from (IDYA) for Rule-Based Strategy - news.stocktradersdaily.com
Ideaya Biosciences stock hits 52-week high at $33.64 By Investing.com - Investing.com Nigeria
Ideaya Biosciences stock hits 52-week high at $33.64 - Investing.com
Finanzdaten der Ideaya Biosciences Inc-Aktie (IDYA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):